Fabry disease and Gaucher disease are rare genetic lysosomal storage disorders characterized by defective degradation of glycosphingolipids due to enzymatic deficiencies in α–galactosidase A and β–glucocerebrosidase, respectively [1, 2]. Patients with Fabry disease suffer from...
Fabry disease (FD; OMIM #301500) is an X-linked inherited lysosomal storage disease due to deficient α-galactosidase A activity (AGAL/GLA) based on pathogenic mutations within the GLA gene. The resulting FD-specific symptoms and manifestations originate from systemic cellular lysosomal...
Rare diseases in the US are defined by a prevalence of fewer than 200,000 individuals [1, 2]. Although individually unusual, rare diseases cumulatively affect approximately 4% of the global population and represent millions of individuals [3, 4]. Clinical trials pose a particular challenge to the rare...
No data are available. Not Applicable. https://doi.org/10.1136/pn-2024-004506...
Fabry disease (FD) is a rare, X-linked, lysosomal storage disorder that results from deficient α-galactosidase A (α-Gal A) activity caused by a variant of the α-galactosidase (GLA) gene, with a prevalence estimated at around 1 in 40,000-170,000 births [1,2,3]. FD presents...